We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Galera Therapeutics Inc | NASDAQ:GRTX | NASDAQ | Common Stock |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
0.1902 | 0.204 | 0.204 | 0.1852 | 0.1852 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | -59.08M | -1.0862 | -0.17 | 10.33M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
00:19:20 | 1 | 0.1955 | USD |
Date | Time | Source | Headline |
---|---|---|---|
31/10/2023 | 12:09 | DJN | Galera Shares Halted After FDA Says Avasopasem Needs Additional Phase 3.. |
10/8/2023 | 01:10 | DJN | Stocks to Watch: Applovin, Disney, Galera Therapeutics |
09/8/2023 | 22:23 | DJN | Galera Therapeutics to Reduce Workforce by 70% to Extend Cash Runway |
18/5/2023 | 13:44 | DJN | Galera Therapeutics Gets Orphan Drug Designation for Rucosopasem |
Galera Therapeutics (GRTX) Share Charts1 Year Galera Therapeutics Chart |
|
1 Month Galera Therapeutics Chart |
Intraday Galera Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions